September 26, 2024

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category

TerraTrust nominated for the DQS Sustainability Award 2024 in the “Sustainable Innovation” category
Go back

We are pleased to announce significant news: the first sustainable and biodegradable pregnancy test in Europe developed by Zamann Pharma Support, under the Terra Trust house brand, has been nominated for the prestigious DQS Sustainability Award 2024 in the “Sustainable Innovation” category. This nomination is a confirmation of their tireless commitment to environmental protection and sustainable innovation.

Every year, the DQS Sustainability Awards recognize companies that are pioneers in sustainability. It is one of the most important awards in the field of sustainability, recognizing companies, regardless of their size, for their innovative approaches to promoting environmental protection and social responsibility. This nomination is not only a recognition for Terra Trust, but underscores how necessary sustainable solutions have become in all areas of life, including the healthcare industry.

For Terra Trust, this nomination symbolizes much more than just a recognition of their technical innovation. It highlights the growing importance of environmental protection in a sector traditionally characterized by plastic waste and environmentally harmful disposables. Their product represents a new generation of pregnancy tests that protect the environment without compromising on quality or accuracy.

More Information in German / Original News:

Sustainability Award 2024 TerraTrustDownload

Our latest News

discover more
The EU is providing nearly eight million euros in funding for two collaborative projects led by Heidelberg

The EU is providing nearly eight million euros in funding for two collaborative projects led by Heidelberg

From AI-assisted brain tumor diagnostics to training a new generation of interdisciplinary specialists: Two European collaborative projects are set to advance the diagnostics of tomorrow. They are being coordinated by Professor Dr. Dr. Felix Sahm of the Heidelberg Medical Faculty at Heidelberg University and the Department of Neuropathology at Heidelberg University Hospital. The European Union […]

read more
Two ERC Starting Grants for Scientists at Universität Heidelberg

Two ERC Starting Grants for Scientists at Universität Heidelberg

European Research Council funds groundbreaking projects in paleoclimatology and cancer neuroscience The European Research Council (ERC) is awarding two valuable grants for early career researchers – two ERC Starting Grants – to Heidelberg University. One of them, worth 1.5 million euros, goes to PD Dr. Sophie Warken, who does her research at the Institutes of […]

read more
Three nationwide research projects in the Network of University Medicine under Heidelberg leadership start the next funding phase

Three nationwide research projects in the Network of University Medicine under Heidelberg leadership start the next funding phase

With RACOON-LCS, PENGUIN and CanTEN, Heidelberg University’s Faculty of Medicine is leading projects on lung cancer screening, penicillin allergy and fungal infections within the Network of University Medicine (NUM), together with one other coordinating university for each project. Researchers at the Heidelberg Faculty of Medicine at Heidelberg University are jointly leading three newly launched nationwide […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp